KR930703292A - 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 - Google Patents

신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제

Info

Publication number
KR930703292A
KR930703292A KR1019930702531A KR930702531A KR930703292A KR 930703292 A KR930703292 A KR 930703292A KR 1019930702531 A KR1019930702531 A KR 1019930702531A KR 930702531 A KR930702531 A KR 930702531A KR 930703292 A KR930703292 A KR 930703292A
Authority
KR
South Korea
Prior art keywords
atom
group
substituent
halogen atom
hydrogen atom
Prior art date
Application number
KR1019930702531A
Other languages
English (en)
Inventor
야수히로 쿠라모토
슈이치로 노다
시노부 마루야마
슌소 하토노
하루요 모치즈키
아키라 야자키
Original Assignee
쿠사이 요시히로
와쿠나가 세이야쿠 카부시키카이샤
후지야마 아키라
후지사와 세이야쿠 카부시키카이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쿠사이 요시히로, 와쿠나가 세이야쿠 카부시키카이샤, 후지야마 아키라, 후지사와 세이야쿠 카부시키카이샤 filed Critical 쿠사이 요시히로
Publication of KR930703292A publication Critical patent/KR930703292A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

하기 일반식(1)
〔식중, R1은 수소 원자, 할로겐 원자, 또는 카르복시 보호기를 나타내며, R2는 수소 원자, 할로겐 원자, 또는 저급 알킬기를 나타내며, X는 수소 원자 또는 할로겐 원자를 나타내고, Y는 할로겐 원자, 치환기를 가져도 좋은 환상 아미노기, 치환기를 가져도 좋은 시클로 저급 알케닐기 또는 식 R3-(CH2)m-A(여기서, R3는 수소 원자 또는 치환기 아미노기를 나타내고, A는 탄소원자 또는 유황원자를 나타내고, m은 0~3의 수를 나타낸다)로 표시되는 기를 나타내고, Z는 질소 원자 또는 C-R4(여기서, R4는 수소 원자 또는 할로겐 원자를 나타낸다)를 나타내고, W는 3개 이상의 헤테로 원자를 가지며, 그 중 적어도 2개의 헤테로 원자가 질소 원자인 치환기를 가져도 좋은 5원 복소환식 기를 나타내고, n은 0~2의 수를 나타낸다〕로 표시되는 퀴놀린 유도체 또는 그의 염 및 이 화합물을 유효성분으로 하는 항균제.
상기 화합물은 강한 항균 작용을 나타내며, 또한 안전성도 높기 때문에 인체 및 동물용 의약품, 어병약(魚病藥), 농약, 식품보존제등에 유용하다.

Description

신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 하기 일반식(1)
    〔식중, R1은 수소 원자, 할로겐 원자, 또는 카르복시 보호기를 나타내며, R2는 수소 원자, 할로겐 원자, 또는 저급 알킬기를 나타내며, X는 수소 원자 또는 할로겐 원자를 나타내고, Y는 할로겐 원자, 치환기를 가져도 좋은 환상 아미노기, 치환기를 가져도 좋은 시클로 저급 알케닐기 또는 식 R3-(CH2)m-A(여기서, R3는 수소 원자 또는 치환기 아미노기를 나타내고, A는 탄소원자 또는 유황원자를 나타내고, m은 0~3의 수를 나타낸다)로 표시되는 기를 나타내고, Z는 질소 원자 또는 C-R4(여기서, R4는 수소 원자 또는 할로겐 원자를 나타낸다)를 나타내고, W는 3개 이상의 헤테로 원자를 가지며, 그 중 적어도 2개의 헤테로 원자가 질소 원자인 치환기를 가져도 좋은 5원 복소환식 기를 나타내고, n은 0~2의 수를 나타낸다〕으로 표시되는 퀴놀론유도체 또는 그의 염.
  2. Y로 표시되는 치환기를 가져도 좋은 환상아미노기가 질소원자 1개를 갖는 포화 또는 불포화 단환식 3~7원의 환상아미노기, 질소원자 2개를 갖는 포화 또는 불포화의 단환식 3~7원의 환상아미노기 또는 산소원자 및 유황원자로 부터 선택된 할로겐원자를 갖는 포화 또는 불포화의 단환식 3~7원의 환상아미노기인 청구범위 제1항 기재의 퀴놀론유도체 또는 그의 염.
  3. W가 각각 치환기를 가져도 좋은 티아디아졸릴기, 트리아졸릴기, 옥사디아졸릴기, 또는 테트라졸릴기인 청구범위 제1항 기재의 퀴놀론 유도체 또는 그의 염.
  4. 청구범위 제1항 기재의 퀴놀론유도체 또는 그의 염을 유효성분으로 하는 항균제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930702531A 1991-12-27 1992-12-25 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 KR930703292A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34657791 1991-12-27
JP91-346577 1991-12-27
PCT/JP1992/001712 WO1993013091A1 (en) 1991-12-27 1992-12-25 Novel quinolone derivative or salt thereof and antibacterial containing the same

Publications (1)

Publication Number Publication Date
KR930703292A true KR930703292A (ko) 1993-11-29

Family

ID=18384366

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930702531A KR930703292A (ko) 1991-12-27 1992-12-25 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제

Country Status (4)

Country Link
US (1) US5412098A (ko)
EP (1) EP0596126A4 (ko)
KR (1) KR930703292A (ko)
WO (1) WO1993013091A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4431122A1 (de) * 1994-09-01 1996-03-07 Bayer Ag Neue Thiazolo[3,2-a]chinolin- und -naphthyridinderivate
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
AU2001253418A1 (en) * 2000-04-12 2001-10-30 Smith Kline Beecham Corporation Compounds and methods
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
JP2004515548A (ja) * 2000-12-14 2004-05-27 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン
AU3089302A (en) 2000-12-14 2002-06-24 Procter & Gamble Antimicrobial 2-pyridones, their compositions and uses
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
WO2004091627A2 (en) * 2003-04-07 2004-10-28 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
WO2005100349A2 (en) * 2004-04-13 2005-10-27 Icagen, Inc. Polycyclic pyridines as potassium ion channel modulators
EP1742904B1 (en) * 2004-05-06 2012-10-31 The Regents of The University of California Substituted enaminones, their derivatives and uses thereof
US7412791B2 (en) * 2004-12-20 2008-08-19 Lsi Industries, Inc. Adjustable menu panel
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
BRPI0709772B8 (pt) * 2006-03-28 2021-05-25 The Protecter & Gamble Company sais de malato e polimorfos do ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-diidro-8-metóxi-4-oxo-3-quinolinocarboxílico
CA2647454A1 (en) * 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
CN102627630A (zh) * 2012-03-16 2012-08-08 西南大学 喹诺酮类化合物及其制备方法和应用
US11286255B2 (en) 2017-03-24 2022-03-29 Wakunaga Pharmaceutical Co., Ltd. Pyridone carboxylic acid derivative or salt thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
US4617308A (en) * 1985-01-25 1986-10-14 Warner-Lambert Company 7-substituted amino-1-aryl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and derivatives thereof as antibacterial agents
JPS61251667A (ja) * 1985-04-30 1986-11-08 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環化合物
JPS6233176A (ja) * 1985-08-05 1987-02-13 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP2704428B2 (ja) * 1988-06-15 1998-01-26 富山化学工業株式会社 キノロンカルボン酸誘導体またはその塩
EP0390215B1 (en) * 1989-03-30 1995-06-07 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and salts thereof, preparation process es thereof, and antibacterial agents containing the same
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives

Also Published As

Publication number Publication date
US5412098A (en) 1995-05-02
WO1993013091A1 (en) 1993-07-08
EP0596126A1 (en) 1994-05-11
EP0596126A4 (en) 1994-06-08

Similar Documents

Publication Publication Date Title
KR930703292A (ko) 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
DE69232854D1 (de) Bizyklische fibrinogenantagonisten
OA09311A (fr) "Dérivés de 4-benzoylisoxazole, compositions les contenant et leur utilisation comme herbicides".
NL350044I1 (nl) Guanidinederivaten, de bereiding ervan en insekticiden
KR950701640A (ko) 에리트로마이신 유도체(eryhromycin derivative)
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
ATE358484T1 (de) Antidiabetische medikamente
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
EA200100916A1 (ru) Лекарственное средство, содержащее производное сульфопиранозилацилглицерина
KR900001643A (ko) 항균제
KR950702530A (ko) 프로스타글란딘 유도체
KR960702458A (ko) 퀴놀린 유도체 또는 그의 염 및 이를 함유 하는 항균제
KR890008148A (ko) 새로운 세파로스포린 화합물 및 항균제
NO20020804D0 (no) Nye A-500359-derivater
MX9206930A (es) Nuevos compuestos
KR980002033A (ko) 트리아졸 유도체 또는 그 염
KR950702544A (ko) 비페닐메탄 유도체 및 이를 함유하는 약제
ES2092470T3 (es) Derivados de pirrolidina.
KR970700032A (ko) 항 hiv제(anti-hiv agent)
KR890001543A (ko) 당뇨병 치료제
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids
KR950032159A (ko) 티아디아지논 유도체
KR890002099A (ko) 어류용 항균제
KR920701163A (ko) 퀴놀론 카르복실산 유도체

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid